Facebook icon Twitter icon Forward icon

Novo publishes positive Victoza® results

The GLP-1 receptor analogue Victoza® (liraglutide) significantly reduced the risk of major cardiovascular events and death in adults with type 2 diabetes in the LEADER trial, Novo Nordisk has announced.

The drug significantly reduces the risk of the composite primary endpoint of cardiovascular (CV) death, non-fatal myocardial infarction (heart attack) or non-fatal stroke by 13 per cent vs placebo (95 per cent confidence interval [CI]: 0.78; 0.97, p=0.01), in addition to standard of care in 9,340 adults with type 2 diabetes at high CV risk.

To read more, click here

Sanofi unveils iGlarLixi drug results

A combination insulin/GLP-1 agonist drug has shown greater efficacy in controlling type 2 diabetes.

The results of the Sanofi drug iGlarLixi, formerly known as LixiLan, were unveiled at the American Diabetes Association annual meeting in New Orleans.

To read more, click here

The Big Interview – Arjun Panesar

In our first monthly feature, we caught up with Arjun Panesar who is the chief technology officer from the website and online forum Diabetes.co.uk.

He explains why the site, which receives more than 2.5 millions hits a month, has become so popular and how the digital era is transforming the world of diabetes.

To read the interview, click here.

Promising faster-acting insulin aspart results

Adults with type 1 diabetes treated with faster-acting insulin aspart had significantly reduced HbA1c and improved postprandial glucose (PPG) control after two-hours when compared with NovoRapid® (insulin aspart) in a basal-bolus regimen, it has been announced.

To read more, click here

Prevention programme to start in weeks

Thousands of people at risk of type 2 diabetes will start to benefit from the first ever national NHS diabetes prevention programme across 10 areas in the next few weeks.

The Healthier You: NHS Diabetes Prevention Programme was launched in April. It has been estimated that up to 100,000 people a year will benefit from it by 2020. To read more, click here.

Ninjabetic – Seeing beyond diabetic retinopathuy

According to Time Hop, five years ago today was a very important moment in my life.

Although at that time I couldn’t see past the fear and uncertainty I was facing. I had come to a dead end and I couldn’t see my future ahead of me.

This time five years ago I was sitting in a hospital gown, alone in a make-shift pre-procedure room, where I waited over an hour having laser treatment to my eyes. To read more, click here